DE69818516D1 - Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten - Google Patents

Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten

Info

Publication number
DE69818516D1
DE69818516D1 DE69818516T DE69818516T DE69818516D1 DE 69818516 D1 DE69818516 D1 DE 69818516D1 DE 69818516 T DE69818516 T DE 69818516T DE 69818516 T DE69818516 T DE 69818516T DE 69818516 D1 DE69818516 D1 DE 69818516D1
Authority
DE
Germany
Prior art keywords
acid
phenylaminoalkyl
compositions containing
medical compositions
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69818516T
Other languages
English (en)
Other versions
DE69818516T2 (de
Inventor
Tetsuro Tamai
Nobuyuki Tanaka
Harunobu Mukaiyama
A Hirabayashi
Hideyuki Muranaka
Masaaki Sato
Masuo Akahane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69818516D1 publication Critical patent/DE69818516D1/de
Publication of DE69818516T2 publication Critical patent/DE69818516T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69818516T 1997-12-18 1998-12-11 Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten Expired - Lifetime DE69818516T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP37008797 1997-12-18
JP37008797 1997-12-18
PCT/JP1998/005605 WO1999031045A1 (fr) 1997-12-18 1998-12-11 Derives d'acide phenylaminoalkylcarboxylique et compositions medicamenteuses les contenant

Publications (2)

Publication Number Publication Date
DE69818516D1 true DE69818516D1 (de) 2003-10-30
DE69818516T2 DE69818516T2 (de) 2004-07-08

Family

ID=18496040

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69818516T Expired - Lifetime DE69818516T2 (de) 1997-12-18 1998-12-11 Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten

Country Status (23)

Country Link
US (1) US6353025B1 (de)
EP (1) EP1043308B1 (de)
JP (1) JP4156799B2 (de)
KR (1) KR100545474B1 (de)
AR (1) AR017858A1 (de)
AT (1) ATE250570T1 (de)
AU (1) AU754317B2 (de)
CA (1) CA2315235C (de)
CO (1) CO5070654A1 (de)
CZ (1) CZ296433B6 (de)
DE (1) DE69818516T2 (de)
ES (1) ES2209226T3 (de)
HU (1) HUP0100102A3 (de)
IL (1) IL136612A (de)
MY (1) MY120466A (de)
NO (1) NO20003105L (de)
NZ (1) NZ505103A (de)
PE (1) PE20000131A1 (de)
PL (1) PL341221A1 (de)
SA (1) SA99191012B1 (de)
TW (1) TW503229B (de)
WO (1) WO1999031045A1 (de)
ZA (1) ZA9811655B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69919860T2 (de) 1998-04-14 2005-08-25 Kissei Pharmaceutical Co., Ltd., Matsumoto 2-methylpropionsäure-derivate und sie enthaltende medizinische zubereitungen
US20030018061A1 (en) * 2000-01-28 2003-01-23 Kohei Ogawa Novel remedies with the use of beta 3 agonist
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
US6653323B2 (en) 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
JP3815496B2 (ja) * 2002-11-07 2006-08-30 アステラス製薬株式会社 酢酸アニリド誘導体を有効成分とする過活動膀胱治療剤
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
WO2004106283A1 (ja) * 2003-05-28 2004-12-09 Kissei Pharmaceutical Co., Ltd. アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途
WO2006002875A1 (en) 2004-07-02 2006-01-12 Bracco Imaging Spa Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
US8109981B2 (en) 2005-01-25 2012-02-07 Valam Corporation Optical therapies and devices
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
AU2009301797B2 (en) 2008-10-09 2012-03-01 Asahi Kasei Pharma Corporation Indazole derivative
CA2740772A1 (en) 2008-10-09 2010-04-15 Asahi Kasei Pharma Corporation Indazole compounds
US20100222404A1 (en) * 2008-11-04 2010-09-02 Asahi Kasei Pharma Corporation Indazole derivative dihydrochloride
PT2554168T (pt) 2010-03-29 2018-02-28 Astellas Pharma Inc Composição farmacêutica de libertação controlada

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
EP0068669A1 (de) * 1981-06-20 1983-01-05 Beecham Group Plc Sekundäre Phenyläthanolamine, Verfahren zu deren Herstellung und deren pharmazeutische Verwendung
DE3368258D1 (en) 1982-07-16 1987-01-22 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
ZA835126B (en) * 1982-07-16 1984-06-27 Beecham Group Plc Secondary amines
GB8528633D0 (en) 1985-11-21 1985-12-24 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
HUP0100102A2 (hu) 2001-05-28
CZ296433B6 (cs) 2006-03-15
WO1999031045A1 (fr) 1999-06-24
AR017858A1 (es) 2001-10-24
CZ20002244A3 (cs) 2000-11-15
NO20003105L (no) 2000-08-17
JP4156799B2 (ja) 2008-09-24
EP1043308A4 (de) 2001-11-14
EP1043308B1 (de) 2003-09-24
CA2315235A1 (en) 1999-06-24
CO5070654A1 (es) 2001-08-28
ES2209226T3 (es) 2004-06-16
MY120466A (en) 2005-10-31
PE20000131A1 (es) 2000-03-15
PL341221A1 (en) 2001-03-26
EP1043308A1 (de) 2000-10-11
IL136612A0 (en) 2001-06-14
NO20003105D0 (no) 2000-06-16
TW503229B (en) 2002-09-21
IL136612A (en) 2003-11-23
AU754317B2 (en) 2002-11-14
KR20010024747A (ko) 2001-03-26
SA99191012B1 (ar) 2006-07-03
ATE250570T1 (de) 2003-10-15
US6353025B1 (en) 2002-03-05
AU1506199A (en) 1999-07-05
HUP0100102A3 (en) 2002-11-28
CA2315235C (en) 2009-07-28
NZ505103A (en) 2003-03-28
KR100545474B1 (ko) 2006-01-24
DE69818516T2 (de) 2004-07-08
ZA9811655B (en) 1999-06-23

Similar Documents

Publication Publication Date Title
ATE267161T1 (de) Phenoxyessigsäure-verbindungen und medizinische zusammensetzungen, die diese enthalten
ATE309206T1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
DE69730980D1 (de) 6-phenyltetrahydro-1,3-oxazin-2-on derivate und medizinische zusammensetzungen, die sie enthalten
DE69711640T2 (de) Naphthopyrane, zusammensetzungen und artikel die diese enthalten
ATE337311T1 (de) Heterocyclylalkylpiperidinderivate, deren herstellung und zusammensetzungen, die diese derivate enthalten
DE60121813D1 (de) Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten
PT914118E (pt) 3,5-difenil-1,2,4-triazoles substituidos e sua utilizacao como quelantes farmaceuticos de metais
ATE335753T1 (de) Glucopyranosyloxybenzylbenzol derivate und medizinische zusammensetzungen, die diese verbindungen enthalten
DE69707650T2 (de) Reinigungsmittel die xanthangummi und vernetzte polyacylsäure enthalten
DE3876400D1 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
DE69842237D1 (de) Azeotropische Zusammensetzungen enthaltend 1,1,1,2,3,3,3-Heptafluorpropan und Verfahren, die diese Zusammensetzungen verwenden
DE69723398D1 (de) Polyalkylphenoxyaminoalkane und diese enthaltende freibstoffzusammensetzungen
DE69832171D1 (de) Derivate des 4-chinolols und land- und gartenbauwirtschaftliche bakterizide, die diese als aktiven bestandteil enthalten
DE69916586D1 (de) Indol-derivate und medizinische zusammensetzungen die diese enthalten
DE69715442T2 (de) Fluorierte triallylisocyanurate, vulkanisierbare elastomerzusammensetzungen die diese enthalten, und vulkanisationsverfahren
DE69818516D1 (de) Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten
ATE222897T1 (de) Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen,die sie enthalten
DE69840091D1 (de) Rostschutzpigmentzusammensetzung und rostschutzlacke die diese enthalten
ATE252883T1 (de) Schweisshemmende mittel und zusammensetzungen die diese enthalten
DE60037826D1 (de) Gene von felincalizivirus und impstoffe, die diese gene enthalten
DE60012353D1 (de) Polyorthoester und härtbare zusammensetzung, die diese enthalten
DE69710623D1 (de) Clathraten und essbare Zusammenzetzungen die diese enthalten
DE69902427D1 (de) Hetero-ethynyl-verbindungen und diese enthaltende zusammensetzungen und kosmetika
DE69931038D1 (de) Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten
DE69942424D1 (de) Neuartige agarofuran derivate, ihre herstellung, pharmazeutische zusammensetzungen, die diese enthalten und ihre verwendung als medizin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition